Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT01785693
Eligibility Criteria:
Inclusion Criteria:
* Patients to benefit a planned femoropopliteal bypass through PAOD stage II or III.
* Aged 18 to 80 years.
* Having given their consent.
* Affiliated with a social security scheme.
Exclusion Criteria:
* Patients with PAOD stage I or IV.
* Chronic respiratory failure.
* Severe coronary insufficiency.
* Renal or hepatic impairment.
* Patients with chronic pain or preoperative long-term opioid treatment.
* Patients with cognitive impairment (judged by the investigator) that may interfere with:
* informed consent,
* the collection of endpoints,
* the use of patient-controlled analgesia.
* Severe abnormality of hemostasis (platelets \<80.000 / ml) and / or of coagulation (PT \<50%, factor V \<50%).
* Patients with diabetes mellitus and / or diabetic neuropathy.
* Pregnant or nursing women, women of childbearing age.
* Refusal of the protocol.
* Minor or major protected patients.
* Contraindications to one of the following products:
levobupivacaine, clonidine, morphine, paracetamol, nefopam.
\- Patients with a contra-indication to the administration of sufentanil: hypersensitivity to any component, hypersensitivity to morphine, hypersensitivity to opiates.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01785693
Study Brief:
Protocol Section:
NCT01785693